Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
168.36 USD
-0.7%
Market Closed
Updated:
Apr 24, 2024
Abbvie Inc
Common Shares Outstanding
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Common Shares Outstanding Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$535.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$257.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$109.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Common Shares Outstanding
$188.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
See Also
What is Abbvie Inc's Common Shares Outstanding?
Common Shares Outstanding
1.8B
USD
1.8B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Common Shares Outstanding amounts to 1.8B USD.
What is Abbvie Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
1%
1%
Over the last year, the Common Shares Outstanding growth was 0%.
You don't have any saved screeners yet
